ABSTRACT The relationship of features of beryllium disease to the estimated exposure to beryllium has been investigated over a 30-year period at a factory manufacturing beryllium products. The factory opened in 1952. Of the 146 men who had worked there for more than six months up to 1963, 89% were seen at that time and were followed up in 1973. The nine who continued to work in the factory and those who were engaged subsequently were examined in 1977. On each occasion a clinical interview, occupational history, chest radiograph, and assessment of lung function were carried out. The findings of the main survey were related to the beryllium content of the dust measured by mass spectrometry for 1952-60 when over 3000 determinations were made. In no part of the plant did the estimated average daily exposure exceed 2 μg m, and only 9% of individual determinations exceeded this level. Twenty determinations exceeded 25 μg m. During the period under review, four men developed the clinical, radiographic, and physiological features of beryllium disease. Two men acquired abnormal chest radiographs consistent with beryllium disease but without other features, and one developed probable beryllium disease despite the diagnosis not being confirmed at necropsy. The affected men were all exposed to beryllium oxide or hydroxide but in a wide range of estimated doses. In six the changes developed after exposure had ceased; trigger factors including patch testing may have contributed to their illness. Seventeen men recalled episodes of brief exposure to high concentrations of dust, two developed pneumonitis from which they recovered completely, and one developed chronic beryllium disease after a further 23 years' exposure. In subjects without clinical or radiographic evidence of disease no convincing evidence was obtained for any association between the lung function and the estimated exposure to beryllium.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1009111PMC
http://dx.doi.org/10.1136/oem.40.1.13DOI Listing

Publication Analysis

Top Keywords

beryllium disease
20
beryllium
11
exposed beryllium
8
features beryllium
8
estimated exposure
8
exposure beryllium
8
lung function
8
determinations exceeded
8
clinical radiographic
8
disease
6

Similar Publications

Article Synopsis
  • Podoconiosis is a non-infectious tropical lymphoedema affecting around 4 million people, linked to HLA class II and triggered by unknown factors in volcanic red clay soils.
  • The study measured immune responses in podoconiosis patients by analyzing cytokine levels and gene expressions after exposure to specific minerals, finding that patients had higher baseline cytokine levels but lower responses to mineral stimulation.
  • The findings indicate ongoing immune activation in podoconiosis patients, highlighting the need for further research to understand immune dysfunction and potentially develop early detection methods for this preventable disease.
View Article and Find Full Text PDF

Sarcoidosis in Beryllium Exposed Workers: A Case-Case Study.

Am J Ind Med

January 2025

Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver, Colorado, USA.

Background: Despite the utility of the beryllium lymphocyte proliferation test (BeLPT), distinguishing sarcoidosis, a disease of unknown etiology, from chronic beryllium disease (CBD), has long posed a diagnostic challenge. It is unclear if beryllium-exposed sarcoidosis cases (Be-exp-Sarc) are clinically distinct from CBD, or are misdiagnosed cases of CBD.

Methods: We performed a case-case study of 40 beryllium-exposed individuals diagnosed with Be-exp-Sarc compared to 40 frequency-matched CBD cases.

View Article and Find Full Text PDF

[Determination of 22 elements in whole blood by inductively coupled plasma mass spectrometry].

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi

September 2024

School of Public Health, Guangxi Medical University, Nanning 530021, China.

Article Synopsis
  • A new method using inductively coupled plasma mass spectrometry (ICP-MS) was developed to simultaneously measure 22 elements in whole blood, including metals like iron and lead.
  • The method involved optimizing various analysis conditions, diluting blood samples with specific chemicals, and centrifuging them before measurement.
  • Results showed strong linear relationships for element detection, with limits of detection and good precision, making it a quick and efficient option for clinical testing of multiple blood elements.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic beryllium disease (CBD) is an interstitial lung condition caused by inhaling beryllium particles, and it can often be confused with sarcoidosis but has distinct characteristics and complications.
  • A case involving a 60-year-old man revealed multi-organ involvement, with his kidney issues stemming from CBD rather than typical pulmonary symptoms, which were relatively mild.
  • The report emphasizes the need for healthcare providers to consider CBD as a potential diagnosis in patients exhibiting granulomatous diseases, especially when they present with related respiratory issues, despite the absence of classical lung symptoms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!